Acute activation of AMP-activated protein kinase prevents h 2o 2-induced premature senescence in primary human keratinocytes

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Ido, Yasuo ^a   Duranton, Albert ^b   Lan, Fan ^a   Cacicedo, Jose M ^a   Chen, Tai C ^a   Breton, Lionel ^b   Ruderman, Neil B ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b L ORÉAL RECHERCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; RESVERATROL; SHORT HAIRPIN RNA; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; DRUG DERIVATIVE; RIBONUCLEOTIDE;

ARTICLE; CELL AGING; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; CYTOCHEMISTRY; DOWN REGULATION; EMBRYO CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; FIBROSARCOMA; HUMAN; HUMAN CELL; INCUBATION TIME; KERATINOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; ADENOVIRUS; APOPTOSIS; DRUG EFFECT; GENE VECTOR; GENETICS; METABOLISM;

ADENOVIRIDAE; AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; CELL AGING; ENZYME ACTIVATION; GENETIC VECTORS; HUMANS; HYDROGEN PEROXIDE; KERATINOCYTES; RIBONUCLEOTIDES; SIGNAL TRANSDUCTION;

EID: 84859702732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035092     Document Type: Article

References (48)

1. Campisi J, d'Adda di Fagagna F, (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740.
2. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363-9367.
3. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, et al. (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479: 232-236.
4. Hayflick L, Moorhead PS, (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
5. Collado M, Blasco MA, Serrano M, (2007) Cellular senescence in cancer and aging. Cell 130: 223-233.
6. Shelton DN, Chang E, Whittier PS, Choi D, Funk WD, (1999) Microarray analysis of replicative senescence. Curr Biol 9: 939-945.
7. Pelle E, Huang X, Mammone T, Marenus K, Maes D, et al. (2003) Ultraviolet-B-induced oxidative DNA base damage in primary normal human epidermal keratinocytes and inhibition by a hydroxyl radical scavenger. J Invest Dermatol 121: 177-183.
8. Bernard D, Gosselin K, Monte D, Vercamer C, Bouali F, et al. (2004) Involvement of Rel/nuclear factor-kappaB transcription factors in keratinocyte senescence. Cancer Res 64: 472-481.
9. Oakhill JS, Scott JW, Kemp BE, (2009) Structure and function of AMP-activated protein kinase. Acta Physiol (Oxf) 196: 3-14.
10. Steinberg GR, Kemp BE, (2009) AMPK in Health and Disease. Physiol Rev 89: 1025-1078.
11. Ido Y, Zou M, Chen K, Cohen R, Keaney JF, et al. (2002) The AMP-kinase (AMPK) activator, AICAR, inhibits the increase in oxidative stress induced by hyperglycemia and palmitate. Diabetes 51: A396.
12. Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, et al. (2006) Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 55: 120-127.
13. Xie Z, Zhang J, Wu J, Viollet B, Zou MH, (2008) Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes. Diabetes 57: 3222-3230.
14. Cacicedo JM, Yagihashi N, Keaney JF Jr, Ruderman NB, Ido Y, (2004) AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun 324: 1204-1209.
15. Hattori Y, Suzuki K, Hattori S, Kasai K, (2006) Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 47: 1183-1188.
16. Jager S, Handschin C, St-Pierre J, Spiegelman BM, (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A 104: 12017-12022.
17. Colombo SL, Moncada S, (2009) AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J 421: 163-169.
18. Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, et al. (2007) The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 282: 30107-30119.
19. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, et al. (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18: 283-293.
20. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, et al. (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331: 456-461.
21. Zhao M, Klionsky DJ, (2011) AMPK-dependent phosphorylation of ULK1 induces autophagy. Cell Metab 13: 119-120.
22. Amato S, Liu X, Zheng B, Cantley L, Rakic P, et al. (2011) AMP-activated protein kinase regulates neuronal polarization by interfering with PI 3-kinase localization. Science 332: 247-251.
23. Fu D, Wakabayashi Y, Ido Y, Lippincott-Schwartz J, Arias IM, (2010) Regulation of bile canalicular network formation and maintenance by AMP-activated protein kinase and LKB1. J Cell Sci 123: 3294-3302.
24. Sinclair DA, Guarente L, (2006) Unlocking the secrets of longevity genes. Sci Am 294: 48-51 54-47.
25. Richter EA, Ruderman NB, (2009) AMPK and the biochemistry of exercise: implications for human health and disease. Biochem J 418: 261-275.
26. Ruderman N, Prentki M, (2004) AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 3: 340-351.
27. Wang W, Yang X, Lopez de Silanes I, Carling D, Gorospe M, (2003) Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function. J Biol Chem 278: 27016-27023.
28. Cao C, Lu S, Kivlin R, Wallin B, Card E, et al. (2009) SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. J Cell Mol Med 13: 3632-3643.
29. Saha AK, Persons K, Safer JD, Luo Z, Holick MF, et al. (2006) AMPK regulation of the growth of cultured human keratinocytes. Biochem Biophys Res Commun 349: 519-524.
30. Lan F, Cacicedo JM, Ruderman N, Ido Y, (2008) SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 283: 27628-27635.
31. Huber M, Limat A, Wagner E, Hohl D, (2000) Efficient in vitro transfection of human keratinocytes with an adenovirus-enhanced receptor-mediated system. J Invest Dermatol 114: 661-666.
32. Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, et al. (2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283: 20015-20026.
33. Zhou G, Myers R, Li Y, Chen Y, Shen X, et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174.
34. Nemoto S, Fergusson MM, Finkel T, (2004) Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306: 2105-2108.
35. Maclaine NJ, Hupp TR, (2009) The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway. Aging (Albany NY) 1: 490-502.
36. Gauthier MS, O'Brien EL, Bigornia S, Mott M, Cacicedo JM, et al. (2011) Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem Biophys Res Commun 404: 382-387.
37. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, et al. (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133: 1006-1018.
38. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, et al. (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133: 1019-1031.
39. Wang W, Yang X, Kawai T, Lopez de Silanes I, Mazan-Mamczarz K, et al. (2004) AMP-activated protein kinase-regulated phosphorylation and acetylation of importin alpha1: involvement in the nuclear import of RNA-binding protein HuR. J Biol Chem 279: 48376-48388.
40. Sung JY, Woo CH, Kang YJ, Lee KY, Choi HC, (2011) AMPK induces vascular smooth muscle cell senescence via LKB1 dependent pathway. Biochem Biophys Res Commun 413: 143-148.
41. Imamura K, Ogura T, Kishimoto A, Kaminishi M, Esumi H, (2001) Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem Biophys Res Commun 287: 562-567.
42. Ido Y, Carling D, Ruderman N, (2002) Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes 51: 159-167.
43. Chen MB, Shen WX, Yang Y, Wu XY, Gu JH, et al. (2011) Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell. J Cell Physiol 226: 1915-1925.
44. Chen MB, Wu XY, Gu JH, Guo QT, Shen WX, et al. (2011) Activation of AMP-activated protein kinase contributes to doxorubicin-induced cell death and apoptosis in cultured myocardial H9c2 cells. Cell Biochem Biophys 60: 311-322.
45. Hayashi T, Matsui-Hirai H, Miyazaki-Akita A, Fukatsu A, Funami J, et al. (2006) Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci U S A 103: 17018-17023.
46. Sone H, Kagawa Y, (2005) Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48: 58-67.
47. Chen TC, Persons K, Liu WW, Chen ML, Holick MF, (1995) The antiproliferative and differentiative activities of 1,25-dihydroxyvitamin D3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes. J Invest Dermatol 104: 113-117.
48. Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P, (2004) Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 18: 703-710.